Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation
Importance: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks' gestational age (GA) who received surfactant treatment while spontaneously breathing.
Objective: To analyze outcomes among LISA-exposed, highly vulnerable babies born at less than 27 weeks' GA within the large-scale observational cohort of the German Neonatal Network.
Design, Setting, and Participants: In this cohort study of data from 68 tertiary level neonatal intensive care units in Germany of infants born between 22 weeks 0 days to 26 weeks 6 days of gestation between April 1, 2009, and December 31, 2020, short-term outcomes among infants receiving LISA vs infants not receiving LISA were compared.
Exposure: Use of LISA within the first 72 hours of life.
Main Outcomes and Measures: The main outcomes were rates of LISA use, use of mechanical ventilation within the first 72 hours (considered failure of LISA), and association of LISA with outcomes, including death from all causes, bronchopulmonary dysplasia (BPD), death and BPD combined, pneumothorax, retinopathy of prematurity, intracerebral hemorrhage, and periventricular leukomalacia. To address potential confounding factors, multivariate logistic regression models were used.
Results: A total of 6542 infants (3030 [46.3%] female and 3512 [53.7%] male; mean [SD] GA, 25.3 (1.1) weeks; mean [SD] birth weight, 715 [180] g) were analyzed; 2534 infants (38.7%) received LISA, which was most frequently given quasi-prophylactically during delivery room management. Among the infants who received LISA, 1357 (53.6%) did not require mechanical ventilation in the first 72 hours compared with 331 infants (8.3%) of 4008 who did not receive LISA. In a multivariate logistic regression model that adjusted for GA, small-for-GA status, sex, multiple birth, inborn status, antenatal steroid use, and maximum fraction of inspired oxygen in the first 12 hours of life, LISA was associated with reduced risks of all-cause death (odds ratio [OR], 0.74; 95% CI, 0.61-0.90; P = .002), BPD (OR, 0.69; 95% CI, 0.62-0.78; P < .001), and BPD or death (OR, 0.64; 95% CI, 0.57-0.72; P < .001) compared with infants without LISA exposure.
Conclusions and Relevance: The results of this long-term multicenter cohort study suggest that LISA may be associated with reduced risks of adverse outcomes in extremely preterm infants.
| Errataetall: |
ErratumIn: JAMA Netw Open. 2023 Apr 3;6(4):e2312619. - PMID 37083673 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
JAMA network open - 5(2022), 8 vom: 01. Aug., Seite e2225810 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Härtel, Christoph [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 11.08.2022 Date Revised 21.04.2023 published: Electronic ErratumIn: JAMA Netw Open. 2023 Apr 3;6(4):e2312619. - PMID 37083673 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamanetworkopen.2022.25810 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344631443 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344631443 | ||
| 003 | DE-627 | ||
| 005 | 20231226023224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamanetworkopen.2022.25810 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM344631443 | ||
| 035 | |a (NLM)35943742 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Härtel, Christoph |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.08.2022 | ||
| 500 | |a Date Revised 21.04.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: JAMA Netw Open. 2023 Apr 3;6(4):e2312619. - PMID 37083673 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Importance: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks' gestational age (GA) who received surfactant treatment while spontaneously breathing | ||
| 520 | |a Objective: To analyze outcomes among LISA-exposed, highly vulnerable babies born at less than 27 weeks' GA within the large-scale observational cohort of the German Neonatal Network | ||
| 520 | |a Design, Setting, and Participants: In this cohort study of data from 68 tertiary level neonatal intensive care units in Germany of infants born between 22 weeks 0 days to 26 weeks 6 days of gestation between April 1, 2009, and December 31, 2020, short-term outcomes among infants receiving LISA vs infants not receiving LISA were compared | ||
| 520 | |a Exposure: Use of LISA within the first 72 hours of life | ||
| 520 | |a Main Outcomes and Measures: The main outcomes were rates of LISA use, use of mechanical ventilation within the first 72 hours (considered failure of LISA), and association of LISA with outcomes, including death from all causes, bronchopulmonary dysplasia (BPD), death and BPD combined, pneumothorax, retinopathy of prematurity, intracerebral hemorrhage, and periventricular leukomalacia. To address potential confounding factors, multivariate logistic regression models were used | ||
| 520 | |a Results: A total of 6542 infants (3030 [46.3%] female and 3512 [53.7%] male; mean [SD] GA, 25.3 (1.1) weeks; mean [SD] birth weight, 715 [180] g) were analyzed; 2534 infants (38.7%) received LISA, which was most frequently given quasi-prophylactically during delivery room management. Among the infants who received LISA, 1357 (53.6%) did not require mechanical ventilation in the first 72 hours compared with 331 infants (8.3%) of 4008 who did not receive LISA. In a multivariate logistic regression model that adjusted for GA, small-for-GA status, sex, multiple birth, inborn status, antenatal steroid use, and maximum fraction of inspired oxygen in the first 12 hours of life, LISA was associated with reduced risks of all-cause death (odds ratio [OR], 0.74; 95% CI, 0.61-0.90; P = .002), BPD (OR, 0.69; 95% CI, 0.62-0.78; P < .001), and BPD or death (OR, 0.64; 95% CI, 0.57-0.72; P < .001) compared with infants without LISA exposure | ||
| 520 | |a Conclusions and Relevance: The results of this long-term multicenter cohort study suggest that LISA may be associated with reduced risks of adverse outcomes in extremely preterm infants | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Pulmonary Surfactants |2 NLM | |
| 650 | 7 | |a Surface-Active Agents |2 NLM | |
| 700 | 1 | |a Herting, Egbert |e verfasserin |4 aut | |
| 700 | 1 | |a Humberg, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Hanke, Kathrin |e verfasserin |4 aut | |
| 700 | 1 | |a Mehler, Katrin |e verfasserin |4 aut | |
| 700 | 1 | |a Keller, Titus |e verfasserin |4 aut | |
| 700 | 1 | |a Mauer, Isabell |e verfasserin |4 aut | |
| 700 | 1 | |a Frieauff, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Meyer, Sascha |e verfasserin |4 aut | |
| 700 | 1 | |a Thome, Ulrich H |e verfasserin |4 aut | |
| 700 | 1 | |a Wieg, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidtke, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Kribs, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Göpel, Wolfgang |e verfasserin |4 aut | |
| 700 | 0 | |a German Neonatal Network |e verfasserin |4 aut | |
| 700 | 1 | |a Faust, Kirstin |e investigator |4 oth | |
| 700 | 1 | |a Müller, Dirk |e investigator |4 oth | |
| 700 | 1 | |a Gebauer, Corinna |e investigator |4 oth | |
| 700 | 1 | |a Guthmann, Florian |e investigator |4 oth | |
| 700 | 1 | |a von der Wense, Axel |e investigator |4 oth | |
| 700 | 1 | |a Stangl, Oliver |e investigator |4 oth | |
| 700 | 1 | |a Weller, Ursula |e investigator |4 oth | |
| 700 | 1 | |a Höhn, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Olbertz, Dirk |e investigator |4 oth | |
| 700 | 1 | |a Felderhoff-Müser, Ursula |e investigator |4 oth | |
| 700 | 1 | |a Rossi, Rainer |e investigator |4 oth | |
| 700 | 1 | |a Teig, Norbert |e investigator |4 oth | |
| 700 | 1 | |a Heitmann, Friedhelm |e investigator |4 oth | |
| 700 | 1 | |a Heckmann, Matthias |e investigator |4 oth | |
| 700 | 1 | |a Laux, Reinhard |e investigator |4 oth | |
| 700 | 1 | |a Bohnhorst, Bettina |e investigator |4 oth | |
| 700 | 1 | |a Roth, Bernd |e investigator |4 oth | |
| 700 | 1 | |a Vochem, Matthias |e investigator |4 oth | |
| 700 | 1 | |a Keller-Wackerbauer, Annette |e investigator |4 oth | |
| 700 | 1 | |a Möller, Jens |e investigator |4 oth | |
| 700 | 1 | |a Eichhorn, Joachim |e investigator |4 oth | |
| 700 | 1 | |a Wintgens, Jürgen |e investigator |4 oth | |
| 700 | 1 | |a Böttger, Ralf |e investigator |4 oth | |
| 700 | 1 | |a Reese, Jochen |e investigator |4 oth | |
| 700 | 1 | |a Hubert, Mechthild |e investigator |4 oth | |
| 700 | 1 | |a Dördelmann, Michael |e investigator |4 oth | |
| 700 | 1 | |a Hillebrand, Georg |e investigator |4 oth | |
| 700 | 1 | |a Roll, Claudia |e investigator |4 oth | |
| 700 | 1 | |a Jensen, Reinhard |e investigator |4 oth | |
| 700 | 1 | |a Rüdiger, Mario |e investigator |4 oth | |
| 700 | 1 | |a Werner, Claudius |e investigator |4 oth | |
| 700 | 1 | |a Longardt, Ann Carolin |e investigator |4 oth | |
| 700 | 1 | |a Schäfer, Stefan |e investigator |4 oth | |
| 700 | 1 | |a Schaible, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Franz, Axel |e investigator |4 oth | |
| 700 | 1 | |a Heldmann, Michael |e investigator |4 oth | |
| 700 | 1 | |a Kunzmann, Steffen |e investigator |4 oth | |
| 700 | 1 | |a Schmidt, Esther |e investigator |4 oth | |
| 700 | 1 | |a Orlikowsky, Thorsten |e investigator |4 oth | |
| 700 | 1 | |a Gerleve, Hubert |e investigator |4 oth | |
| 700 | 1 | |a Depping, Nico |e investigator |4 oth | |
| 700 | 1 | |a Haase, Roland |e investigator |4 oth | |
| 700 | 1 | |a Hoppenz, Marc |e investigator |4 oth | |
| 700 | 1 | |a Seeliger, Stephan |e investigator |4 oth | |
| 700 | 1 | |a Küster, Helmut |e investigator |4 oth | |
| 700 | 1 | |a Fuchs, Hans |e investigator |4 oth | |
| 700 | 1 | |a Körner, Thorsten |e investigator |4 oth | |
| 700 | 1 | |a Brune, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Müller, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Urlichs, Florian |e investigator |4 oth | |
| 700 | 1 | |a Berghäuser, Martin |e investigator |4 oth | |
| 700 | 1 | |a Proquitté, Hans |e investigator |4 oth | |
| 700 | 1 | |a Morhart, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Lindner, Wolfgang |e investigator |4 oth | |
| 700 | 1 | |a Schlösser, Rolf |e investigator |4 oth | |
| 700 | 1 | |a Schneider, Welfhard |e investigator |4 oth | |
| 700 | 1 | |a Schroth, Michael |e investigator |4 oth | |
| 700 | 1 | |a Rieger-Fackeldey, Esther |e investigator |4 oth | |
| 700 | 1 | |a Dohle, Frank |e investigator |4 oth | |
| 700 | 1 | |a Sinnecker, Gernot |e investigator |4 oth | |
| 700 | 1 | |a Völkl, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Brevis Nunez, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Welsch, Michael |e investigator |4 oth | |
| 700 | 1 | |a Krüger, Marcus |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA network open |d 2018 |g 5(2022), 8 vom: 01. Aug., Seite e2225810 |w (DE-627)NLM289300517 |x 2574-3805 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2022 |g number:8 |g day:01 |g month:08 |g pages:e2225810 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamanetworkopen.2022.25810 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2022 |e 8 |b 01 |c 08 |h e2225810 | ||